Oncolytics Biotech® Raises $15M to Advance Cancer Clinical Programs

Leede Jones Gable Inc. acted as underwriter and bookrunner (the "Underwriter") in accordance with the terms of an underwriting agreement between the Compan...

August 09, 2023 | Wednesday | News
Agilent Launches its First Integrated Biology Center at Monash University in Malaysia

Agilent Technologies Inc. (NYSE: A)  announced the opening of a new full-scale Integrated Biology Center located at Monash University in Malaysia...

August 08, 2023 | Tuesday | News
Merck's CEO Belén Garijo Optimistic About 2023 as Healthcare Business Drives Growth

Financial results of Q2 2023 Net sales decrease organically by −1.1% to € 5.3 billion EBITDA pre down organically by −7.0% t...

August 08, 2023 | Tuesday | Company results
GERO and FOXO Join Forces for AI-Driven Human Health Trajectory Discovery

This collaboration occurs in the wake of recent advancements from GERO, which sparked vigorous discussion among longevity experts in the scientific communi...

August 08, 2023 | Tuesday | News
ImPact Biotech Gets FDA Clearance for Padeliporfin VTP Phase 1 in Lung Cancer

 ImPact Biotech, the IMmune Photo Activated Cancer Treatment (IMPACT) specialist announces the U.S. Food and Drug Administrat...

August 07, 2023 | Monday | News
LianBio Begins Phase 1 Trial for SHP2 Inhibitor BBP-398 Combo with Osimertinib in EGFR-Mutated Lung Cancer

SHP2 is a protein-tyrosine phosphatase that links growth factor, cytokine and integrin signaling with the downstream RAS/MAPK pathway to regulate cellular ...

August 04, 2023 | Friday | News
Piramal Pharma Reports Strong Start to Financial Year with Revenue Surge and Promising Growth Prospects Across Business Segments, Says Chairperson Nandini Piramal

Nandini Piramal, Chairperson, Piramal Pharma Limited said, "We had a positive start to the new financial year with healthy revenue growth and improvem...

August 04, 2023 | Friday | News
Collaboration Shines as BIO Asia–Taiwan 2023 Concludes

Event co-organizer the Taiwan Bio Industry Organization (Taiwan BIO), stated that international participation was notably higher this year due to the lifti...

August 02, 2023 | Wednesday | News
Guardant Settles Litigation with Illumina, Forges New Partnership for Cancer Research

he three-year agreement includes a joint request to dismiss with prejudice the pending litigation between the companies, including any allegations related ...

August 02, 2023 | Wednesday | News
IDTechEx Examines the Role of Antimicrobial Technology in Combating Healthcare Infections.

Each year, millions of patients contract infectious diseases while in hospital. These HAIs not only lengthen hospital stays and utilize resources, such as ...

July 31, 2023 | Monday | News
Australia: First Patient Dosed in Chemotherapy-Free Soft Tissue Sarcoma Trial.

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immu...

July 31, 2023 | Monday | News
EmVenio Research & TrialHub Partner to Boost Clinical Trial Efficiency

Through TrialHub's data intelligence gathering platform, EmVenio can easily identify optimal markets to attract clinical trial participants who are needed ...

July 28, 2023 | Friday | News
Bio-Rad and QIAGEN announce patent settlement and cross-licensing agreement

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA)  announced that the companies have agreed ...

July 27, 2023 | Thursday | News
Bharat Serums and Vaccines Initiates Compliance Measures for Assisted Reproduction Methods

India based biopharmaceutical firm Bharat Serums and Vaccines has roped in Bureau Veritas (India) Pvt. Ltd. (BVIL), a world leader in Audit and Certificati...

July 26, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close